GLOPID-R

07/03/2022

Upcoming webinar: Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies

The second webinar in the ZonMw series ‘Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies’ will be held on Monday April 4, 2022, from 5pm to 6pm CET.

The Netherlands Organisation for Health Research and Development (ZonMw)

ZonMw is organizing this series of webinars to cover the different ongoing studies in the Netherlands to investigate vaccination against COVID-19 in people with a compromised immune system. The aim is to transfer knowledge to an (inter)national audience of researchers, practitioners, informed patients and policy makers.

In this edition, researchers from Erasmus MC and Amsterdam UMC will share results from the VACOPID study: patients with primary immunodeficiencies, and the COBRA-KAI study: patients with a hematological condition.

Register for the webinar

More information

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.